New diabetes clinical trial: Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle

Published on: February 18, 2026 at 11:00PM
Conditions: Overweight and Obesity
Interventions: Drug: ATR-258
Sponsors: Morten Hostrup, PhD; Atrogi AB; University of Copenhagen; Stockholm University
Not yet recruiting
https://ift.tt/vUzbC1y